Adeno-associated virus serotype 9 antibodies in patients screened for treatment with onasemnogene abeparvovec.
Ontology highlight
ABSTRACT: Spinal muscular atrophy is a progressive, recessively inherited monogenic neurologic disease, the genetic root cause of which is the absence of a functional survival motor neuron 1 gene. Onasemnogene abeparvovec (formerly AVXS-101) is an adeno-associated virus serotype 9 vector-based gene therapy that delivers a fully functional copy of the human survival motor neuron gene. We report anti-adeno-associated virus serotype 9 antibody titers for patients with spinal muscular atrophy when they were screened for eligibility in the onasemnogene abeparvovec clinical trials (intravenous and intrathecal administration) and managed access programs (intravenous). Through December 31, 2019, 196 patients and 155 biologic mothers were screened for anti-adeno-associated virus serotype 9 bind
SUBMITTER: Day JW
PROVIDER: S-EPMC7973120 | biostudies-literature | 2021 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA